Robert M. Rifkin, MD, FACP, discusses how findings from real-world studies on teclistamab and talquetamab presented at the 66th American Society of Hematology Annual Meeting and Exposition reinforce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results